JP2003528100A5 - - Google Patents

Download PDF

Info

Publication number
JP2003528100A5
JP2003528100A5 JP2001568941A JP2001568941A JP2003528100A5 JP 2003528100 A5 JP2003528100 A5 JP 2003528100A5 JP 2001568941 A JP2001568941 A JP 2001568941A JP 2001568941 A JP2001568941 A JP 2001568941A JP 2003528100 A5 JP2003528100 A5 JP 2003528100A5
Authority
JP
Japan
Prior art keywords
cabergoline
toluene
diethyl ether
ether mixture
resulting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001568941A
Other languages
English (en)
Japanese (ja)
Other versions
JP4184666B2 (ja
JP2003528100A (ja
Filing date
Publication date
Priority claimed from GBGB0007308.0A external-priority patent/GB0007308D0/en
Application filed filed Critical
Publication of JP2003528100A publication Critical patent/JP2003528100A/ja
Publication of JP2003528100A5 publication Critical patent/JP2003528100A5/ja
Application granted granted Critical
Publication of JP4184666B2 publication Critical patent/JP4184666B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001568941A 2000-03-24 2001-03-19 カベルゴリンの結晶性形態iを調製するための方法 Expired - Fee Related JP4184666B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0007308.0A GB0007308D0 (en) 2000-03-24 2000-03-24 Process for preparing crystalline form | of cabergoline
GB0007308.0 2000-03-24
PCT/EP2001/003099 WO2001070740A1 (en) 2000-03-24 2001-03-19 Process for preparing crystalline form i of cabergoline

Publications (3)

Publication Number Publication Date
JP2003528100A JP2003528100A (ja) 2003-09-24
JP2003528100A5 true JP2003528100A5 (cg-RX-API-DMAC10.html) 2006-01-05
JP4184666B2 JP4184666B2 (ja) 2008-11-19

Family

ID=9888433

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001568941A Expired - Fee Related JP4184666B2 (ja) 2000-03-24 2001-03-19 カベルゴリンの結晶性形態iを調製するための方法

Country Status (31)

Country Link
US (2) US6727363B2 (cg-RX-API-DMAC10.html)
EP (1) EP1272489B1 (cg-RX-API-DMAC10.html)
JP (1) JP4184666B2 (cg-RX-API-DMAC10.html)
KR (1) KR100827558B1 (cg-RX-API-DMAC10.html)
CN (1) CN1188412C (cg-RX-API-DMAC10.html)
AR (1) AR032449A1 (cg-RX-API-DMAC10.html)
AT (1) ATE250601T1 (cg-RX-API-DMAC10.html)
AU (2) AU780747B2 (cg-RX-API-DMAC10.html)
BR (1) BR0109507A (cg-RX-API-DMAC10.html)
CA (1) CA2402836A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ20023176A3 (cg-RX-API-DMAC10.html)
DE (1) DE60100858T2 (cg-RX-API-DMAC10.html)
DK (1) DK1272489T3 (cg-RX-API-DMAC10.html)
EA (1) EA005928B1 (cg-RX-API-DMAC10.html)
EE (1) EE05088B1 (cg-RX-API-DMAC10.html)
ES (1) ES2208602T3 (cg-RX-API-DMAC10.html)
GB (1) GB0007308D0 (cg-RX-API-DMAC10.html)
HK (1) HK1052348B (cg-RX-API-DMAC10.html)
HU (1) HUP0300591A3 (cg-RX-API-DMAC10.html)
IL (2) IL150985A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA02009283A (cg-RX-API-DMAC10.html)
MY (1) MY134189A (cg-RX-API-DMAC10.html)
NO (1) NO20024321L (cg-RX-API-DMAC10.html)
NZ (1) NZ521316A (cg-RX-API-DMAC10.html)
PE (1) PE20011140A1 (cg-RX-API-DMAC10.html)
PL (1) PL358253A1 (cg-RX-API-DMAC10.html)
PT (1) PT1272489E (cg-RX-API-DMAC10.html)
SI (1) SI1272489T1 (cg-RX-API-DMAC10.html)
SK (1) SK13582002A3 (cg-RX-API-DMAC10.html)
WO (1) WO2001070740A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200206045B (cg-RX-API-DMAC10.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0007308D0 (en) 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Process for preparing crystalline form | of cabergoline
GB0007307D0 (en) * 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Crystalline form || of cabergoline
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
RS81804A (sr) * 2002-03-15 2006-10-27 Pharmacia Corporation Postupak za dobijanje kristalnog oblika kabergolina
WO2003078392A2 (en) * 2002-03-15 2003-09-25 Pharmacia Corporation Process for preparing crystalline form i of cabergoline
IL155545A (en) 2003-04-21 2009-12-24 Finetech Pharmaceutical Ltd Solvate form of cabergoline
AU2004238833A1 (en) * 2003-05-08 2004-11-25 Ivax Pharmaceuticals S.R.O. Polymorphs of cabergoline
GB0409785D0 (en) * 2004-04-30 2004-06-09 Resolution Chemicals Ltd Preparation of cabergoline
GB0505965D0 (en) 2005-03-23 2005-04-27 Resolution Chemicals Ltd Preparation of cabergoline
GB0515430D0 (en) * 2005-07-27 2005-08-31 Resolution Chemicals Ltd Preparation of cabergoline
US7339060B2 (en) 2005-03-23 2008-03-04 Resolution Chemicals, Ltd. Preparation of cabergoline
EP1925616A1 (en) * 2006-10-26 2008-05-28 LEK Pharmaceuticals D.D. Process for the preparation of crystal forms of cabergoline via stable solvates of cabergoline
EP1953157A1 (en) 2007-01-31 2008-08-06 LEK Pharmaceuticals D.D. New crystal form of cabergoline
US8637099B2 (en) * 2007-08-29 2014-01-28 Max Zeller Sohne Ag Use of Vitex agnus castus extracts for preparing a medicament
EP4074552B1 (en) * 2021-04-16 2024-04-03 Thermo King LLC Electrical connection unit

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3019322A1 (de) 1980-05-21 1981-12-03 Merck Patent Gmbh, 6100 Darmstadt Psychopharmakon sowie verwendung von adenosinderivaten
US4526892A (en) * 1981-03-03 1985-07-02 Farmitalia Carlo Erba, S.P.A. Dimethylaminoalkyl-3-(ergoline-8'βcarbonyl)-ureas
GB2103603B (en) * 1981-08-11 1985-04-11 Erba Farmitalia Ergoline derivatives
GB9205439D0 (en) * 1992-03-12 1992-04-22 Erba Carlo Spa Process for the synthesis of ergoline derivatives
JPH08502759A (ja) 1993-08-18 1996-03-26 アルコン ラボラトリーズ,インコーポレイテッド 緑内障治療用のエルゴリン誘導体の使用
US20020010197A1 (en) 1998-01-13 2002-01-24 John Dixon Pharmaceutical compositions comprising a compound having dopamine (d2) receptor agonist activity and a compound (b) having beta2-adrenoreceptor agonist activity
PL343593A1 (en) 1998-03-27 2001-08-27 Upjohn Co Use of cabergoline in the treatment of restless legs syndrome
GB0007308D0 (en) 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Process for preparing crystalline form | of cabergoline
GB0007309D0 (en) 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Crystalline form V|| of cabergoline
GB0007307D0 (en) 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Crystalline form || of cabergoline

Similar Documents

Publication Publication Date Title
RO116276B1 (ro) Procedeu de purificare a melaminei
RU2003111948A (ru) Способы получения кристаллов в-типа натеглинида
WO2000031014A8 (en) Process of purifying and producing high purity aromatic polycarboxylic acids and derivatives thereof
JPH11124372A5 (cg-RX-API-DMAC10.html)
CN113979987A (zh) 一种高纯碳酸乙烯酯的提纯装置和方法
JP2003528094A5 (cg-RX-API-DMAC10.html)
CN109133467B (zh) 一种回收酸化法生产烟酸的洗涤水中烟酸和氯化铵的方法
KR950003255A (ko) 정제된 에틸렌 글리콜 카보네이트(egc)의 분리방법
CN102502530A (zh) 静态熔融结晶生产电子级硫酸的方法
WO2001042133A1 (en) Method for producing lithium hexafluorophosphate
CA1056835A (en) Process for recovering nicotinic amide
EP2374786A1 (en) Purification of monochloroacetic acid rich streams
CA1191664A (en) Method for producing sodium persulfate
JPH0669889B2 (ja) 層状ケイ酸塩の水熱合成法
US2734058A (en) Process for the production of solid finely
JP2002506064A5 (cg-RX-API-DMAC10.html)
RU2131843C1 (ru) Способ получения кремния высокой чистоты
ZA200302072B (en) Method and devices for producing naphthalene from coke produced from coke oven crude gas.
JPH0361605B2 (cg-RX-API-DMAC10.html)
TH52584A (th) กระบวนการสำหรับเตรียมรูปผลึกที่ i ของคาเบอร์โกลีน
CN1308013A (zh) 无水硫化钠晶体的制备方法
JPH0254820B2 (cg-RX-API-DMAC10.html)
US2490633A (en) Purification of ammonium beryllium fluoride
CN1053664C (zh) 四聚乙醛生产工艺
KR20190056265A (ko) 층상형 MnBi, MnBi 나노시트 및 이들의 제조방법